“What if your grandfather could manage his diabetes without using cumbersome test papers and confusing information? What if a 7-year-old child with diabetes does not have to face the tension or fear every time he pierces his finger? These are the obstacles that the current continuous blood glucose monitoring (CGM) technology has overcome, and they are also the problems that ADI has solved by embedding breakthrough technology in the continuous blood glucose monitoring (CGM) equipment.
“
What if your grandfather could manage his diabetes without using cumbersome test papers and confusing information? What if a 7-year-old child with diabetes does not have to face the tension or fear every time he pierces his finger? These are the obstacles that the current continuous blood glucose monitoring (CGM) technology has overcome, and they are also the problems that ADI has solved by embedding breakthrough technology in the continuous blood glucose monitoring (CGM) equipment.
CGM is a mobile device for diabetic patients. It inserts a tiny sensor under the skin to test blood sugar levels around the clock. It is a better solution for quickly and accurately monitoring diabetes. Both diabetic patients and their doctors can obtain real-time information without encountering many obstacles caused by traditional testing methods.
However, this is not a perfect solution-at least not for now. The main obstacle to the CGM technical solution is always the combination of size, weight and power (SWaP). After all, CGM is a portable vital signs monitoring (VSM) device that is usually worn on the arms or belly of diabetic patients. However, because it needs to maintain power to collect data, it is difficult to design it to work properly without affecting the size of the wearer.
As a leader in digital healthcare solutions, especially in the areas of wearable technology and chronic disease management, ADI’s expertise is sufficient to meet this SWaP challenge. We have been working hard to help CGM technology manufacturers (especially China Miqi) develop smaller and smarter devices. In the end, we successfully developed a new technology to help realize a new generation of VSM technology that is convenient and low-interference.
As digital healthcare is getting closer and closer to the forefront of international medical dialogue, the demand for VSM technology has increased dramatically. At present, the global demand for digital health innovation has reached an unprecedented level, especially for technologies that can keep people healthy and away from hospitals. In this sense, an independent monitoring system that can directly send information to doctors and the cloud also promotes the development of public health and popularity in an indirect way.
Advances in the field of VSM are critical to groups such as diabetic patients and medical and health professionals. With the widespread application of VSM technology, diabetic patients can achieve accuracy and active data collection that cannot be achieved by fingertip blood detection methods. What if your grandfather had the tools needed to prevent complications such as vascular damage, heart disease, stroke, and kidney disease, and had information about his diabetes in advance? In other words, what if a 7-year-old girl could wear a cool little computer on her arm to monitor her health instead of performing terrible acupuncture? We believe that there are many similar cases that can enable people to live happier and healthier lives. The increase in data enables patients to actively manage their own health, thereby reducing the burden on the medical and health system by reducing the number of hospitalizations and the need for emergency treatment.
Finally, ADI’s motivation for improving CGM technology is also the motivation for all our pursuits: constantly seeking breakthroughs to make life better. As one of Meiqi’s contacts stated, “The cooperation with ADI, ADI’s system-level understanding and domain expertise are all outstanding. It turns out that they are more than just a component company.”
The Links: AT93C66-10TI-27 CXA-0256
0 Comments for “Personal impact of continuous blood glucose monitoring (CGM) technology”